March 2025 Life Sciences Update

VC Funding by Market

09

CONTENTS

VC Deal Volume: Life Science (Year to Q4 24)

Growth in Deal Volume (Year to Q4 24)

Volume (Euro mn)

Share of all VC Funding (RHS)

138%

XXX

4,000

45%

40%

97%

3,500

94%

35%

3,000

30%

41%

2,500

37%

22%

25%

15% 16%

2,000

6%

1%

20%

1,500

15%

-24% -24% -22%

GLA sqm

1,000

10%

-49%

500

5%

0

0%

Source: Cushman & Wakefield, Pitchbook

Cushman & Wakefield

48